Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Andrew Hopkins | M | 52 |
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | 12 Jahre |
| Elizabeth Crain | F | 59 |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | 3 Jahre |
| David Hallett | M | 54 | 4 Jahre | |
| Ben Taylor | M | 46 |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | 4 Jahre |
| Michel de Rosen | M | 73 | 6 Jahre | |
| Dan Ireland | M | - |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | - |
| C. Nicholson | M | 69 |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | 4 Jahre |
| Mario Polywka | M | 61 | 7 Jahre | |
| Chris Thomas | M | - |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | 5 Jahre |
| Amanda Galgay | F | - |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | 2 Jahre |
| Garry Pairaudeau | M | 58 |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | 4 Jahre |
| Joanne Xu | F | 46 |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | 3 Jahre |
| Pascal Wotling | M | - | 4 Jahre | |
| Robert Ghenchev | M | 41 |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | 4 Jahre |
| Daniel Tassé | M | 64 | 6 Jahre | |
| Julie O'Neill | F | 58 | 7 Jahre | |
| John Overington | M | - | 3 Jahre | |
| Richard Henry Cheetham Bickerton | M | 80 | 3 Jahre | |
| Caroline Daniere | F | 50 | 5 Jahre | |
| Mark Basil Swindells | M | - |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | - |
| Angela Marcucci | F | - | 4 Jahre | |
| Dave Hallett | M | 54 |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | 4 Jahre |
| Caroline Rowland | F | - | 2 Jahre | |
| Pharis Mohideen | M | 59 | 5 Jahre | |
| Eileen Jennings-Brown | F | - | 2 Jahre | |
| Franziska Michor | M | 41 | 1 Jahre | |
| Parker Moss | M | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Pierre-Henri Benhamou | M | 69 | 17 Jahre | |
| David S. Schilansky | M | 48 | 8 Jahre | |
| Laurent Martin | M | 57 | 12 Jahre | |
| Charles Ruban | M | 52 | 7 Jahre | |
| Susanna Mesa | F | 38 | 5 Jahre | |
| Viviane Monges | F | 60 | 3 Jahre | |
| Michael Krams | M | 63 | 2 Jahre | |
| Bertrand Dupont | M | 72 | 16 Jahre | |
| Guillaume Hagège | M | - | - | |
| Richard Cox | M | - | - | |
| Adrian Schreyer | M | - | 4 Jahre | |
| Xia Milly Chen | F | - | 4 Jahre | |
| Ben Ashwell-Fryer | M | - | 4 Jahre | |
| Kevin Trapp | M | - | 2 Jahre | |
| Alan Kerr | M | - | - | |
| Ramzi Benamar | M | 51 | - | |
| Joe Becker | M | - | - | |
| Joan Schmidt | F | 60 | 2 Jahre | |
| Magali Richard | M | 42 | 3 Jahre | |
| Septien-Velez Septién | M | 62 | 3 Jahre | |
| Charlotte Deane | M | - | 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigtes Königreich | 26 | 54,17% |
| Frankreich | 22 | 45,83% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Sara Blum Sherman
- Persönliches Netzwerk
